Song P Y, Washington M, Vaida F, Hamilton R, Spelbring D, Wyman B, Harrison J, Chen G T
Michael Reese/University Chicago, Center for Radiation and Cellular Oncology, Chicago, IL, USA.
Int J Radiat Oncol Biol Phys. 1996 Jan 1;34(1):213-9. doi: 10.1016/0360-3016(95)02094-2.
To determine the variability of patient positioning during three-dimensional conformal radiotherapy (3D-CRT) for prostate cancer treated with no immobilization or one of four immunobilization devices, and to determine the effects of patient body habitus and pelvic circumference on patient movement with each individual inmobilization technique.
To see whether our immobilization techniques have improved day-to-day patient movement, a retrospective analysis was carried out. A total of 62 patients treated at one facility on a single machine with 3D-CRT via a four-field box technique (anterior-posterior and opposed laterals) in the supine position with either no immobilization or one of four immobilization devices. Five groups of patients were compared: (a) group 1-no immobilization; (b) group 2-alpha cradle from the waist to upper thigh; (c) group 3-alpha cradle from waist to below the knees; (d) group 4-styrofoam leg immobilizer (below knees); and (e) group 5-aquaplast cast encompassing the entire abdomen and pelvis to midthigh with alpha cradle immobilization to their lower legs and feet. Prior to starting radiotherapy, portal films of all four treatment fields were obtained 1 day before treatment. Subsequently, portal films were then obtained at least once a week. Portal films were compared with the simulation films and appropriate changes were made and verified on the next day prior to treatment. A deviation of greater than 0.5 cm or greater was considered to be clincally significant in our analysis. We studied the difference among the types of immobilization and no immobilization by looking at the frequency of movements (overall, and on each of the three axes) that a patient had during the course of his treatment. Using a logistic regression model, the probability of overall and individual directional movement for each group was obtained. In addition, the effects of patient body habitus and pelvic circumference on movement were analyzed.
The maximum deviation was 2 cm and the median deviation was 1.2 cm. For each patient, the probability of movement ranged from 0 to 76%, with a mean of 39%. There was no significant difference seen in overall movement with any of the immobilzation devices compared to no immobilization, but there was less vertical (9 vs. 18%; p = 0.03) and AP (6 vs. 15%; p = 0.14) movement with the aquaplast than any other group. However, when examining the lateral direction, the aquaplast had significantly more movement (32 vs. 9%; p < 0.001). When accounting for body habitus and pelvic circumference, no immobilization device was effective in reducing movement in obese patients or in patients with pelvic circumference greater than 105 cm. The aquaplast group had a significantly increased amount of lateral movement with obesity (42 vs. 23%; p < 0.05), and with pelvic circumference >105 cm (33 vs. 29%; p < 0.05).
There was no significant reduction in overall patient movement noted with any of the immobilization devices compared to no immobilization. The aquaplast group had reduced vertical and AP movement of greater than 0.5 cm. There was significantly more lateral movement with aquaplast appreciated in obese patients or patients with pelvic circumferences greater than 105 cm. The aquaplast immobilization appears to be useful in reducing movement in two very clinicaly important dimensions (AP and vertical). Despite our findings, other immobilization may still be useful especially in the treatment of nonobese patients. It is clear that the optimal immobilization technique and patient positioning are yet to be determined.
确定在三维适形放疗(3D-CRT)治疗前列腺癌时,不使用固定装置或使用四种免疫固定装置之一时患者体位的可变性,并确定患者体型和盆腔周长对每种个体固定技术下患者移动的影响。
为了观察我们的固定技术是否改善了患者每日的移动情况,进行了一项回顾性分析。共有62例患者在同一机构的一台机器上接受3D-CRT治疗,采用四野盒式技术(前后对穿侧野),仰卧位,不使用固定装置或使用四种固定装置之一。比较了五组患者:(a)第1组-不使用固定装置;(b)第2组-从腰部到大腿上部的α型托架;(c)第3组-从腰部到膝盖以下的α型托架;(d)第4组-泡沫塑料腿部固定器(膝盖以下);(e)第组-水凝胶石膏模型覆盖整个腹部和骨盆至大腿中部,小腿和足部采用α型托架固定。在开始放疗前,于治疗前1天获取所有四个治疗野的门静脉造影片。随后,每周至少获取一次门静脉造影片。将门静脉造影片与模拟片进行比较,并在次日治疗前进行适当调整并验证。在我们的分析中,偏差大于0.5 cm或更大被认为具有临床意义。我们通过观察患者在治疗过程中移动的频率(总体以及在三个轴上的每一个轴上)来研究固定类型与不固定之间的差异。使用逻辑回归模型,获得每组总体和个体方向移动的概率。此外,分析了患者体型和盆腔周长对移动的影响。
最大偏差为2 cm,中位偏差为1.2 cm。对于每位患者,移动概率范围为0至76%,平均为39%。与不使用固定装置相比,使用任何固定装置在总体移动方面均未观察到显著差异,但水凝胶石膏模型组的垂直移动(9%对18%;p = 0.03)和前后方向移动(6%对15%;p = 0.14)比其他任何组都少。然而,在检查侧向方向时,水凝胶石膏模型组的移动明显更多(32%对9%;p < 0.001)。在考虑体型和盆腔周长时,没有固定装置在减少肥胖患者或盆腔周长大于105 cm患者的移动方面有效。水凝胶石膏模型组在肥胖患者中侧向移动量显著增加(42%对23%;p < 0.05),在盆腔周长>105 cm的患者中也显著增加(33%对29%;p < 0.05)。
与不使用固定装置相比,使用任何固定装置均未观察到患者总体移动有显著减少。水凝胶石膏模型组减少了大于0.5 cm的垂直和前后方向移动。在肥胖患者或盆腔周长大于105 cm的患者中,水凝胶石膏模型组的侧向移动明显更多。水凝胶石膏模型固定似乎在减少两个非常重要的临床维度(前后和垂直)的移动方面有用。尽管有我们的研究结果,但其他固定方法可能仍然有用,特别是在治疗非肥胖患者时。显然,最佳的固定技术和患者体位尚未确定。